Riskpilot← Back to searchSign inGet full accessAnna Deman AB
ABActiveOrg 5590289277Kämpegatan 15Hospital activities · NACE 8610Est. 20151-4 employees
Revenue 2025
SEK 84K
-93% vs 2024
EBITDA margin
-146.9%
-124% vs 2024
Equity ratio
94.8%
Financial strength
Net profit 2025
SEK -119K
-128% vs 2024
| Revenue | SEK 84K | -93% |
| EBITDA | SEK -124K | -124% |
| Net profit | SEK -119K | -128% |
| Total assets | SEK 959K | -28% |
| Equity | SEK 909K | -26% |
| Employees | — | — |
Legal name
Anna Deman AB
Org number
5590289277
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
5 oktober 2015
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-10-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Specialiserad sluten somatisk sjukvård på sjukhus. Ambulanstransporter och ambulanssjukvård
Address
Kämpegatan 15
Email
anna.deman@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 688 | 1 027 | 1 196 | 1 261 | 84 |
| Staff expenses | — | −567 | −772 | −634 | −158 |
| EBITDA | 155 | 325 | 245 | 508 | −124 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 155 | 325 | 245 | 508 | −124 |
| Net financials | — | −32 | 2 | 22 | 4 |
| Profit before tax | 155 | 293 | 247 | 529 | −119 |
| Tax | −35 | −72 | −50 | −105 | — |
| Net profit | 120 | 221 | 197 | 425 | −119 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 028 | 1 069 | 1 085 | 1 323 | 959 |
| Equity | 958 | 994 | 1 003 | 1 232 | 909 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 70 | 76 | 82 | 91 | 50 |
| Total debt | 70 | 76 | 82 | 91 | 50 |
EBITDA margin
-146.9%
This company
15.8%
Market median
-1030% vs market
20212025
Equity ratio
94.8%
This company
38.2%
Market median
+148% vs market
20212025
Return on equity
-13.1%
This company
18.4%
Market median
-171% vs market
20212025
Net profit margin
-141.8%
This company
8.1%
Market median
-1851% vs market
20212025
Asset turnover
0.09×
This company
1.12×
Market median
-92% vs market
20212025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-11-01 – 2025-10-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-11-01 – 2024-10-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-11-01 – 2023-10-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-11-01 – 2022-10-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-10-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Anna Deman AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Beata Déman | Board of Directors | 0 companies |
| Elin Maria Déman | Deputy Board Member | 0 companies |